Invesco’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.25M | Sell |
161,636
-1,094,191
| -87% | -$35.6M | ﹤0.01% | 2164 |
|
|
2025
Q1 | $47.4M | Buy |
1,255,827
+89,773
| +8% | +$3.39M | 0.01% | 1057 |
|
|
2024
Q4 | $95.5M | Sell |
1,166,054
-146,042
| -11% | -$12M | 0.02% | 828 |
|
|
2024
Q3 | $150M | Buy |
1,312,096
+233,376
| +22% | +$26.7M | 0.03% | 691 |
|
|
2024
Q2 | $81.5M | Sell |
1,078,720
-155,789
| -13% | -$11.8M | 0.02% | 841 |
|
|
2024
Q1 | $84.3M | Buy |
1,234,509
+1,007,558
| +444% | +$68.8M | 0.02% | 835 |
|
|
2023
Q4 | $14.3M | Buy |
226,951
+75,386
| +50% | +$4.73M | ﹤0.01% | 1599 |
|
|
2023
Q3 | $7.73M | Sell |
151,565
-86,574
| -36% | -$4.41M | ﹤0.01% | 1928 |
|
|
2023
Q2 | $11.9M | Buy |
238,139
+198,671
| +503% | +$9.92M | ﹤0.01% | 1686 |
|
|
2023
Q1 | $1.48M | Sell |
39,468
-180,771
| -82% | -$6.78M | ﹤0.01% | 2748 |
|
|
2022
Q4 | $10.6M | Buy |
220,239
+184,189
| +511% | +$8.83M | ﹤0.01% | 1801 |
|
|
2022
Q3 | $864K | Sell |
36,050
-1,546
| -4% | -$37.1K | ﹤0.01% | 2965 |
|
|
2022
Q2 | $818K | Buy |
37,596
+10,407
| +38% | +$226K | ﹤0.01% | 3066 |
|
|
2022
Q1 | $656K | Buy |
27,189
+12,719
| +88% | +$307K | ﹤0.01% | 3235 |
|
|
2021
Q4 | $344K | Sell |
14,470
-2,188
| -13% | -$52K | ﹤0.01% | 3521 |
|
|
2021
Q3 | $423K | Buy |
16,658
+2,095
| +14% | +$53.2K | ﹤0.01% | 3474 |
|
|
2021
Q2 | $328K | Buy |
+14,563
| New | +$328K | ﹤0.01% | 3567 |
|